These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 15191347

  • 1. Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.
    Nørrelund H, Nielsen S, Christiansen JS, Jørgensen JO, Møller N.
    Eur J Endocrinol; 2004 Jun; 150(6):779-87. PubMed ID: 15191347
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.
    Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
    [Abstract] [Full Text] [Related]

  • 3. The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone.
    Nørrelund H, Nair KS, Nielsen S, Frystyk J, Ivarsen P, Jørgensen JO, Christiansen JS, Møller N.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4371-8. PubMed ID: 12970312
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure.
    Nielsen S, Møller N, Christiansen JS, Jørgensen JO.
    Diabetes; 2001 Oct; 50(10):2301-8. PubMed ID: 11574412
    [Abstract] [Full Text] [Related]

  • 5. Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans.
    Gormsen LC, Jessen N, Gjedsted J, Gjedde S, Nørrelund H, Lund S, Christiansen JS, Nielsen S, Schmitz O, Møller N.
    J Clin Endocrinol Metab; 2007 May; 92(5):1834-42. PubMed ID: 17341555
    [Abstract] [Full Text] [Related]

  • 6. Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes.
    Salgin B, Marcovecchio ML, Williams RM, Jackson SJ, Bluck LJ, Humphreys SM, Acerini CL, Dunger DB.
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3297-305. PubMed ID: 19567515
    [Abstract] [Full Text] [Related]

  • 7. Mediation of the hepatic effects of growth hormone by its lipolytic activity.
    Piatti PM, Monti LD, Caumo A, Conti M, Magni F, Galli-Kienle M, Fochesato E, Pizzini A, Baldi L, Valsecchi G, Pontiroli AE.
    J Clin Endocrinol Metab; 1999 May; 84(5):1658-63. PubMed ID: 10323396
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse.
    Bianda TL, Hussain MA, Keller A, Glatz Y, Schmitz O, Christiansen JS, Alberti KG, Froesch ER.
    Diabetologia; 1996 Aug; 39(8):961-9. PubMed ID: 8858219
    [Abstract] [Full Text] [Related]

  • 9. Effects of a 3-day fast on regional lipid and glucose metabolism in human skeletal muscle and adipose tissue.
    Gjedsted J, Gormsen LC, Nielsen S, Schmitz O, Djurhuus CB, Keiding S, Ørskov H, Tønnesen E, Møller N.
    Acta Physiol (Oxf); 2007 Nov; 191(3):205-16. PubMed ID: 17784905
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown.
    Nørrelund H, Nair KS, Jørgensen JO, Christiansen JS, Møller N.
    Diabetes; 2001 Jan; 50(1):96-104. PubMed ID: 11147801
    [Abstract] [Full Text] [Related]

  • 12. Lipid metabolism and insulin resistance in cirrhosis.
    Kaye GL, Kruszynska YT, Harry DS, Heslop K, Johnston DG, McIntyre N.
    J Hepatol; 1994 Jun; 20(6):782-91. PubMed ID: 7930479
    [Abstract] [Full Text] [Related]

  • 13. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC, Frisch F, Cyr D, Généreux P, Patterson BW, Giguère R, Baillargeon JP.
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
    Møller N, Bagger JP, Schmitz O, Jørgensen JO, Ovesen P, Møller J, Alberti KG, Orskov H.
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1789-93. PubMed ID: 7775624
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P, Rossetti P, Porcellati F, Pampanelli S, Candeloro P, Andreoli AM, Perriello G, Bolli GB, Fanelli CG.
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans.
    Gravholt CH, Dall R, Christiansen JS, Møller N, Schmitz O.
    Obes Res; 2002 Aug; 10(8):774-81. PubMed ID: 12181386
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.